Bullatacin

Bullatacin is a lipid of Polyketides (PK) class. The involved functions are known as inhibitors, Electron Transport, NADH-ubiquinone oxidoreductase activity, NADH oxidation and Point Mutation. Bullatacin often locates in NADH dehydrogenase complex and Submitochondrial Particles. The associated genes with Bullatacin are NDUFS7 gene, CCL14 wt Allele and TERT gene. The related lipids are Annonaceous Acetogenins.

Cross Reference

Introduction

To understand associated biological information of Bullatacin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Bullatacin?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Bullatacin

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Neoplasms, Glandular and Epithelial D009375 12 associated lipids
Optic Atrophies, Hereditary D015418 2 associated lipids
Total 4

PubChem Associated disorders and diseases

What pathways are associated with Bullatacin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Bullatacin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Bullatacin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Bullatacin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Bullatacin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Bullatacin?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Bullatacin

Download all related citations
Per page 10 20 50 100 | Total 68
Authors Title Published Journal PubMed Link
pmid:
Xie BF et al. [Antitumor effect of anuoning]. 2002 Ai Zheng pmid:12452015
Carelli V et al. Biochemical features of mtDNA 14484 (ND6/M64V) point mutation associated with Leber's hereditary optic neuropathy. 1999 Ann. Neurol. pmid:10072046
Tormo JR et al. Kinetic characterization of mitochondrial complex I inhibitors using annonaceous acetogenins. 1999 Arch. Biochem. Biophys. pmid:10462447
Myers MA et al. Inhibition of mitochondrial oxidative phosphorylation induces hyper-expression of glutamic acid decarboxylase in pancreatic islet cells. 1999 Autoimmunity pmid:10433094
Estornell E et al. Cherimolin-1, new selective inhibitor of the first energy-coupling site of the NADH: ubiquinone oxidoreductase (complex I). 1997 Biochem. Biophys. Res. Commun. pmid:9367916
Degli Esposti M et al. Natural substances (acetogenins) from the family Annonaceae are powerful inhibitors of mitochondrial NADH dehydrogenase (Complex I). 1994 Biochem. J. pmid:8037664
Chiu HF et al. Bullatacin, a potent antitumor Annonaceous acetogenin, induces apoptosis through a reduction of intracellular cAMP and cGMP levels in human hepatoma 2.2.15 cells. 2003 Biochem. Pharmacol. pmid:12527325
Shimada H et al. Membrane conformations and their relation to cytotoxicity of asimicin and its analogues. 1998 Biochemistry pmid:9454575
Kakutani N et al. Exploring the binding site of delta(lac)-acetogenin in bovine heart mitochondrial NADH-ubiquinone oxidoreductase. 2010 Biochemistry pmid:20459120
Hamada T et al. Synthesis and inhibitory action of novel acetogenin mimics with bovine heart mitochondrial complex I. 2004 Biochemistry pmid:15035635
Masuya T et al. Pinpoint chemical modification of Asp160 in the 49 kDa subunit of bovine mitochondrial complex I via a combination of ligand-directed tosyl chemistry and click chemistry. 2014 Biochemistry pmid:25419630
Duval RA et al. Heterocyclic analogues of squamocin as inhibitors of mitochondrial complex I. On the role of the terminal lactone of annonaceous acetogenins. 2006 Biochemistry pmid:16489765
Ichimaru N et al. Synthesis and inhibition mechanism of Delta lac-acetogenins, a novel type of inhibitor of bovine heart mitochondrial complex I. 2005 Biochemistry pmid:15641810
Takada M et al. Definition of crucial structural factors of acetogenins, potent inhibitors of mitochondrial complex I. 2000 Biochim. Biophys. Acta pmid:11106771
Fato R et al. Differential effects of mitochondrial Complex I inhibitors on production of reactive oxygen species. 2009 Biochim. Biophys. Acta pmid:19059197
Nakanishi S et al. Bis-THF motif of acetogenin binds to the third matrix-side loop of ND1 subunit in mitochondrial NADH-ubiquinone oxidoreductase. 2011 Biochim. Biophys. Acta pmid:21616052
Darrouzet E and Dupuis A Genetic evidence for the existence of two quinone related inhibitor binding sites in NADH-CoQ reductase. 1997 Biochim. Biophys. Acta pmid:9107311
Makabe H et al. Synthesis of (4R,15R,16R,21S)- and (4R,15S,16S,21S)-rollicosin, squamostolide, and their inhibitory action with bovine heart mitochondrial complex I. 2006 Bioorg. Med. Chem. pmid:16431114
Zhao GX et al. The absolute configuration of adjacent bis-THF acetogenins and asiminocin, a novel highly potent asimicin isomer from Asimina triloba. 1996 Bioorg. Med. Chem. pmid:8689234